Tag: Tyrosine kinase inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Tyrosine kinase inhibitors

Vascular Endothelial Growth Factor Inhibitor Market Size, Strategies and Opportunities Forecast 2027

Added to Collection on: 2022-08-22 08:38:32

Tags for this article:

Branches of biology
Growth factors
Cell signaling
Tyrosine kinase receptors
Angiology
Tyrosine kinase inhibitors
Vascular endothelial growth factor
Angiogenesis inhibitor
VEGF receptor
Growth factor receptor inhibitor
C-fos-induced growth factor
Angiogenesis

Click the tags to see associated articles and topics

View Article Details
Alpha Biopharma Announces Completion of its EVEREST Phase II/III Clinical Study of ... - EIN News

Added to Collection on: 2022-08-25 10:43:00

Tags for this article:

Lung cancer
Cancer
Quinazolines
Tyrosine kinase receptors
Organic compounds
Chemical compounds
Tyrosine kinase inhibitors
Non-small-cell lung carcinoma
Epidermal growth factor receptor
Brain metastasis
Icotinib
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
New Approach for Uncovering Tumors' Molecular Dependencies - GenomeWeb

Added to Collection on: 2022-08-26 07:08:30

Tags for this article:

RTT
Chronic lymphocytic leukemia
Cancer
Causes of death
Clinical medicine
Tyrosine kinase inhibitors
Pyrazolopyrimidines
Cancer biomarker
ZAP70

Click the tags to see associated articles and topics

View Article Details
Incyte And Mirati Therapeutics Enter Into Clinical Trial Collaboration and Supply Agreement ...

Added to Collection on: 2022-11-07 13:28:43

Tags for this article:

Medicine
Clinical medicine
Cancer treatments
KRAS
Branches of biology
Tyrosine kinase inhibitors
PD-1 and PD-L1 inhibitors
Incyte
PD-L1
Checkpoint inhibitor
Sitravatinib
Mirati Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Bruton Tyrosine Kinase (BTK) Inhibitors Market with Tremendous growth by 2029 ... - Digital Journal

Added to Collection on: 2022-11-07 15:54:35

Tags for this article:

Tyrosine kinase inhibitors
Organic compounds
Chemical compounds
Branches of biology
Tyrosine kinases
Bruton's tyrosine kinase
Piperidines
Cancer treatments
Tyrosine kinase
Market segmentation
Ibrutinib
Market analysis

Click the tags to see associated articles and topics

View Article Details
Japan approves AstraZeneca's Calquence for adult patients with treatment-naïve CLL

Added to Collection on: 2022-12-29 08:37:03

Tags for this article:

RTT
Medicine
Clinical medicine
Cancer
Tyrosine kinase inhibitors
Breakthrough therapy
Chronic lymphocytic leukemia
Acalabrutinib
SLL
Leukemia
Lymphoma
CLL
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
J&J's Rybrevant in Combo with Lazertinib Clears Phase III in NSCLC - BioSpace

Added to Collection on: 2023-09-28 20:03:05

Tags for this article:

Lung cancer
Breakthrough therapy
Tyrosine kinase inhibitors
Ethers
T790M
Non-small-cell lung cancer
Epidermal growth factor receptor
Amivantamab
Bispecific monoclonal antibody
Protein kinase inhibitor
Osimertinib
Draft:Lazertinib
Johnson & Johnson

Click the tags to see associated articles and topics

View Article Details
Ascentage Pharma and AstraZeneca Investment Co., Ltd. Enter into Clinical Collaboration ...

Added to Collection on: 2023-10-16 16:02:14

Tags for this article:

Antineoplastic drugs
Orphan drugs
Peripheral membrane proteins
Tyrosine kinase inhibitors
Acalabrutinib
Chronic lymphocytic leukemia
Bruton's tyrosine kinase
Bcl-2
AstraZeneca
Targeted therapy
Ibrutinib
P110α
AstraZeneca Group

Click the tags to see associated articles and topics

View Article Details
Lilly cancer drug cleared by FDA for expanded leukemia, lymphoma use - BioPharma Dive

Added to Collection on: 2023-12-04 17:24:48

Tags for this article:

Orphan drugs
Breakthrough therapy
Antineoplastic drugs
Tyrosine kinase inhibitors
Piperidines
Bruton's tyrosine kinase
Ibrutinib
AbbVie
Obinutuzumab
Chemotherapy
Acalabrutinib
Chronic lymphocytic leukemia
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
Evolving Front-line Treatment Options for CLL - Cancer Network

Added to Collection on: 2023-12-18 22:08:57

Tags for this article:

Orphan drugs
Breakthrough therapy
Tyrosine kinase inhibitors
Tyrosine kinases
Piperidines
Bruton's tyrosine kinase
Acalabrutinib
Zanubrutinib
Obinutuzumab
Chronic lymphocytic leukemia
Lymphoid leukemia
Leukemia
Mayo Clinic

Click the tags to see associated articles and topics

View Article Details